AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TALPHERA, INC. Director's Dealing 2018

Aug 7, 2018

Director's Dealing

Opens in your device viewer

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2018-08-07

Reporting Person: Angotti Vincent J. (Director, Chief Executive Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-07	Common Stock	P	10000	$2.895	Acquired	35000	Direct

F1: Balance includes non-reportable acquisition of 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan.